HomeMCRB • NASDAQ
Seres Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.25M | -21.52% |
Net income | -19.86M | 39.60% |
Net profit margin | — | — |
Earnings per share | -2.27 | 48.41% |
EBITDA | -23.82M | 13.22% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.38M | -36.29% |
Total assets | 143.80M | -55.30% |
Total liabilities | 110.85M | -72.88% |
Total equity | 32.95M | — |
Shares outstanding | 8.75M | — |
Price to book | 4.68 | — |
Return on assets | -40.39% | — |
Return on capital | -47.77% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.86M | 39.60% |
Cash from operations | -13.29M | 66.62% |
Cash from investing | -181.00K | -113.90% |
Cash from financing | 0.00 | — |
Net change in cash | -13.47M | 65.02% |
Free cash flow | -9.22M | 63.55% |
Previous close
$17.61
Day range
$16.83 - $18.25
Year range
$6.53 - $24.67
Market cap
157.84M USD
Avg Volume
212.28K
P/E ratio
1.60
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2010
Website
Employees
103
